Pune, India -- (SBWIRE) -- 03/15/2018 -- The Chikungunya Fever Market is segmented on the basis of diagnosis, treatment, and end users. On the basis of diagnosis, the market is segmented into ELISA based assays, serological tests, virological tests, and others. ELISA based assays is futhur segmented into IgM based ELISA and IgG ELISA. On the basis of treatment, the market is segmented into allopathy, homeopathy, ayurveda, and others. The allopathy segmented is sub segmented into anti-pyretics, optimal analgesics, and others. The homeopathy segment is sub segmented into pyroginum, rhus-tox, cedron, and others. The ayurveda segment is sub segmented into amrutharista, mahasudarshana churna, dhanvantaram gutika and others. On the basis of end users, the market is segmented into hospitals and clinics, academic institutes, research laboratories, and others.

Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is no specific antiviral drug treatment for Chikungunya. Treatment is directed primarily at relieving the symptoms. This involves use of anti-pyretics, optimal analgesics in allopathy. Moreover, ayurveda and homeopathy can be employed in the treatment procedures. According to the World Health Organization, the disease mostly occurs in Africa, Asia and the Indian subcontinent. However a major outbreak in 2015 affected several countries of the region of the Americas. This is expected to boost the market growth across the globe during the forecasted period.

Get Sample copy of Chikungunya Fever Market Report@ https://www.marketresearchfuture.com/sample_request/4694 .

Key Players:

The key players for the chikungunya market are Quest Diagnostics Incorporated. (U.S.A), Alere. (U.S.A), Genome Diagnostics Pvt. Ltd. (India), altona Diagnostics (Europe), Bio-Rad Laboratories, Inc. (U.S.A), Sanat Products Ltd. (India), Taj Pharmaceuticals Limited. (India), and Etubics Corporation (U.S.A).

LIST OF TABLES:

Table 1 Chikungunya Fever Industry Synopsis, 2017 – 2023

Table 2 Global Chikungunya Fever Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Chikungunya Fever Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million)

Table 5 Global Chikungunya Fever Market By Treatment, 2017 – 2023, (USD Million)

Table 6 Global Chikungunya Fever Market By End Users, 2017 – 2023, (USD Million)

Table 7 North America Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million)

Table 8 North America Chikungunya Fever Market By Treatment, 2017 – 2023, (USD Million)

Table 9 North America Chikungunya Fever Market By End Users, 2017 – 2023, (USD Million)

Table 10 US Chikungunya Fever Market By Diagnosis, 2017 – 2023, (USD Million) and more.

Get Discount on Chikungunya Fever Market Report @ https://www.marketresearchfuture.com/check-discount/4694 .

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com